The placebo phenomenon: Implications for the ethics of shared decision-making

Howard Brody, Luana Colloca, Franklin G. Miller

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Recent research into the placebo effect has implications for the ethics of shared decision-making (SDM). The older biomedical model views SDM as affecting which therapy is chosen, but not the nature or likelihood of any health outcomes produced by the therapy. Research indicates, however, that both the content and manner in which information is shared with the patient, and the patient's experience of being involved in the decision, can directly alter therapeutic outcomes via placebo responses. An ethical tension is thereby created between SDM aimed strictly and solely at conveying accurate information, and outcome engineering in which SDM is adapted toward therapeutic goals. Several practical strategies mitigate this tension and promote respect for autonomous decision-making while still utilizing the therapeutic potential of SDM.

Original languageEnglish (US)
Pages (from-to)739-742
Number of pages4
JournalJournal of General Internal Medicine
Volume27
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Ethics
Decision Making
Placebos
Therapeutics
Placebo Effect
Research
Health

ASJC Scopus subject areas

  • Internal Medicine

Cite this

The placebo phenomenon : Implications for the ethics of shared decision-making. / Brody, Howard; Colloca, Luana; Miller, Franklin G.

In: Journal of General Internal Medicine, Vol. 27, No. 6, 06.2012, p. 739-742.

Research output: Contribution to journalArticle

Brody, Howard ; Colloca, Luana ; Miller, Franklin G. / The placebo phenomenon : Implications for the ethics of shared decision-making. In: Journal of General Internal Medicine. 2012 ; Vol. 27, No. 6. pp. 739-742.
@article{27305068551f4b238e70fa6241d5811a,
title = "The placebo phenomenon: Implications for the ethics of shared decision-making",
abstract = "Recent research into the placebo effect has implications for the ethics of shared decision-making (SDM). The older biomedical model views SDM as affecting which therapy is chosen, but not the nature or likelihood of any health outcomes produced by the therapy. Research indicates, however, that both the content and manner in which information is shared with the patient, and the patient's experience of being involved in the decision, can directly alter therapeutic outcomes via placebo responses. An ethical tension is thereby created between SDM aimed strictly and solely at conveying accurate information, and outcome engineering in which SDM is adapted toward therapeutic goals. Several practical strategies mitigate this tension and promote respect for autonomous decision-making while still utilizing the therapeutic potential of SDM.",
author = "Howard Brody and Luana Colloca and Miller, {Franklin G.}",
year = "2012",
month = "6",
doi = "10.1007/s11606-011-1977-1",
language = "English (US)",
volume = "27",
pages = "739--742",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - The placebo phenomenon

T2 - Implications for the ethics of shared decision-making

AU - Brody, Howard

AU - Colloca, Luana

AU - Miller, Franklin G.

PY - 2012/6

Y1 - 2012/6

N2 - Recent research into the placebo effect has implications for the ethics of shared decision-making (SDM). The older biomedical model views SDM as affecting which therapy is chosen, but not the nature or likelihood of any health outcomes produced by the therapy. Research indicates, however, that both the content and manner in which information is shared with the patient, and the patient's experience of being involved in the decision, can directly alter therapeutic outcomes via placebo responses. An ethical tension is thereby created between SDM aimed strictly and solely at conveying accurate information, and outcome engineering in which SDM is adapted toward therapeutic goals. Several practical strategies mitigate this tension and promote respect for autonomous decision-making while still utilizing the therapeutic potential of SDM.

AB - Recent research into the placebo effect has implications for the ethics of shared decision-making (SDM). The older biomedical model views SDM as affecting which therapy is chosen, but not the nature or likelihood of any health outcomes produced by the therapy. Research indicates, however, that both the content and manner in which information is shared with the patient, and the patient's experience of being involved in the decision, can directly alter therapeutic outcomes via placebo responses. An ethical tension is thereby created between SDM aimed strictly and solely at conveying accurate information, and outcome engineering in which SDM is adapted toward therapeutic goals. Several practical strategies mitigate this tension and promote respect for autonomous decision-making while still utilizing the therapeutic potential of SDM.

UR - http://www.scopus.com/inward/record.url?scp=84862697930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862697930&partnerID=8YFLogxK

U2 - 10.1007/s11606-011-1977-1

DO - 10.1007/s11606-011-1977-1

M3 - Article

C2 - 22258918

AN - SCOPUS:84862697930

VL - 27

SP - 739

EP - 742

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 6

ER -